| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Sherine E Gabriel | |
| P2860 | cites work | Cardiovascular risk factors in women with and without rheumatoid arthritis | Q28171426 |
| Treatment of patients hospitalized for psoriasis | Q34004162 | ||
| Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
| History of the Rochester Epidemiology Project | Q34374377 | ||
| Glucocorticoids and rheumatoid arthritis: back to the future? | Q34972556 | ||
| Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis | Q35036976 | ||
| Optimizing antihypertensivetreatment in clinical practice | Q35544597 | ||
| Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study | Q35554431 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis | Q35638288 | ||
| Patterns of cardiovascular risk in rheumatoid arthritis | Q35638493 | ||
| Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis | Q35638708 | ||
| Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy | Q35676074 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Inflammation and cardiovascular disease mechanisms | Q36392615 | ||
| Comorbidity in arthritis. | Q40790498 | ||
| Mortality in rheumatoid arthritis: do age and gender make a difference? | Q41089122 | ||
| Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity | Q43483478 | ||
| Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians | Q44170460 | ||
| All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. | Q44724213 | ||
| Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 | ||
| How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? | Q46732422 | ||
| Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction | Q47273525 | ||
| Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 | ||
| Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. | Q50881711 | ||
| Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. | Q50969877 | ||
| Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. | Q51761535 | ||
| Cardiovascular disease in rheumatoid arthritis | Q57307125 | ||
| Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis | Q57540217 | ||
| The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years | Q57540261 | ||
| Mortality in rheumatoid arthritis | Q71125278 | ||
| Length of life and cause of death in rheumatoid arthritis | Q73268669 | ||
| Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset | Q73292550 | ||
| Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992 | Q73560184 | ||
| Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists | Q77940816 | ||
| Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years | Q78794833 | ||
| Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study | Q79850163 | ||
| Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| P433 | issue | 10 Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | S9-14 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Cardiovascular morbidity and mortality in rheumatoid arthritis | |
| P478 | volume | 121 |
| Q35621612 | Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells |
| Q50553806 | Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis |
| Q99632180 | Anti-Inflammatory and Antiarrhythmic Effects of Beta Blocker in a Rat Model of Rheumatoid Arthritis |
| Q51610024 | Arterial stiffness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors. |
| Q33650548 | Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients |
| Q41921823 | Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications |
| Q47263251 | Atrial Fibrillation Promotion in a Rat Model of Rheumatoid Arthritis |
| Q92104941 | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis |
| Q38469239 | Axial spondyloarthritis: the heart of the matter |
| Q38898838 | Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad. |
| Q38591281 | Biosimilars for the management of rheumatoid arthritis: economic considerations |
| Q37307297 | Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis |
| Q57235880 | Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades |
| Q82594213 | Cardiac complications in rheumatoid arthritis in the absence of occlusive coronary pathology |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q43061600 | Cardiovascular disease complications in systemic lupus erythematosus |
| Q35121150 | Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions |
| Q34563216 | Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment |
| Q38124279 | Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery |
| Q38936667 | Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis. |
| Q53315721 | Collagen-induced arthritis increases inducible nitric oxide synthase not only in aorta but also in the cardiac and renal microcirculation of mice. |
| Q37782588 | Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review |
| Q97886132 | Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish |
| Q35070822 | Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis |
| Q41728784 | Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study |
| Q37651150 | Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate? |
| Q87586879 | Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis |
| Q38745362 | Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis |
| Q26749294 | Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis |
| Q34076011 | Endothelial dysfunction in tristetraprolin-deficient mice is not caused by enhanced tumor necrosis factor-α expression |
| Q37624581 | Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases |
| Q99638169 | Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review |
| Q37675607 | Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection |
| Q34238357 | Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity |
| Q64105948 | Gender Differences in Cardiovascular Risk Profile in Rheumatoid Arthritis Patients with Low Disease Activity |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q34495902 | Haematopoietic stem and progenitor cells in rheumatoid arthritis |
| Q36456316 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
| Q99711818 | Incident arterial vascular events in a cohort of Puerto Ricans with rheumatoid arthritis |
| Q37000208 | Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis |
| Q35840716 | Integrated safety in tocilizumab clinical trials |
| Q57658287 | Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort |
| Q36113398 | Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis |
| Q37130018 | Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients |
| Q34328320 | Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. |
| Q37058791 | Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion |
| Q38272682 | Methotrexate revisited: considerations for subcutaneous administration in RA. |
| Q40815110 | Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: |
| Q89930593 | Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population - the Nord-Trøndelag Health Study |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q34610490 | Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based Study |
| Q36112092 | Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study |
| Q90258526 | Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease |
| Q35122015 | Plasma IL-5 concentration and subclinical carotid atherosclerosis |
| Q37730557 | Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. |
| Q90022736 | Predictors of Smoking Cessation in Patients with Rheumatoid Arthritis in Two Cohorts: Healthcare Factors Most Predictive |
| Q41464826 | Prevalence of Asymptomatic Arterial Hypertension and Its Correlation with Inflammatory Activity in Early Rheumatoid Arthritis. |
| Q47094958 | Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals. |
| Q52562359 | Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. |
| Q40638928 | Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. |
| Q47095887 | Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study |
| Q36721379 | Rapid Resolution of Severe Myocardial Dysfunction in a Patient with Rheumatoid Arthritis by Intravenous Immunoglobulin and Steroid Treatment |
| Q41026862 | Red cell distribution width: a measure of cardiovascular risk in rheumatoid arthritis patients? |
| Q34027546 | Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study |
| Q48323417 | Retinal vessel morphology in rheumatoid arthritis: Association with systemic inflammation, subclinical atherosclerosis, and cardiovascular risk |
| Q96952976 | Rheumatoid Arthritis as a Risk Factor for Coronary Artery Calcification and Obstructive Coronary Artery Disease in Patients with Chest Pain: A Registry Based Cross-Sectional Study |
| Q51181626 | Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. |
| Q35124825 | Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. |
| Q34206247 | Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden |
| Q34307622 | Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden |
| Q38665700 | Safety profile of biological therapies for treating rheumatoid arthritis |
| Q55341968 | Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan. |
| Q38405205 | Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. |
| Q39665336 | Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. |
| Q34503198 | Somatic cell plasticity and Niemann-Pick type C2 protein: fibroblast activation |
| Q28076558 | Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date |
| Q50690412 | Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors. |
| Q35098905 | Targeting Nuclear Hormone Receptors: PPARα Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis |
| Q44508845 | The changing face of rheumatoid arthritis: sustained remission for all? |
| Q48299826 | The effect of body mass index on the spread of spinal block in patients with rheumatoid arthritis |
| Q37427394 | The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis |
| Q34164644 | The immune system in atherosclerosis |
| Q51555879 | Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. |
| Q28597791 | Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources |
| Q35954706 | Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality |
| Q37474800 | Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status |
| Q37978685 | β-blockade: benefits beyond blood pressure reduction? |
| Q28080246 | Rituximab for Rheumatoid Arthritis. |
Search more.